Inpharma Weekly

, Volume 983, Issue 1, pp 21–21 | Cite as

Patients prefer IV to SC immunoglobulins

Newsletter Article

Keywords

Adverse Effect Primary Antibody Venous Access Serum Immunoglobulin Infusion Site 

Copyright information

© Adis International Ltd 1995

Personalised recommendations